James Campbell "has more than 17 years of experience in scientific research, research management, management consulting and venture capital in Australia and internationally. He is the Vice-President of Operations for ChemGenex Pharmaceuticals, a US-Australian pharmaceutical company that is listed on the ASX and NASDAQ.
"Previously, James held research positions at the Centre National de la Recherche Scientifique in France and the CSIRO, and after completing an MBA worked for the international management consultancy Booz Allen Hamilton. James later joined the commercial arm of the University of Melbourne, where he sat on the investment committee of the pre-seed venture capital fund UniSeed Pty Ltd, and was a director of several emerging biotech companies." 
- Investment Committee, Symbiosis Group
Resources and articles
Related Sourcewatch articles
- Directors, Symbiosis Group, accessed November 25, 2008.